Navigation Links
University of Hawaii cancer researchers discover gene defect responsible for cancer syndrome
Date:9/6/2012

HONOLULU, HI - University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.

The study investigated two unrelated families with BAP1 defects and found an increase in the occurrence of mole-like melanocytic tumors that are non-cancerous flat or slightly elevated and pigmented skin lesions. These benign skin lesions were found to carry the BAP1 mutation and it was concluded that people with this specific type of melanocytic lesion are at higher risk of developing melanoma and mesothelioma.

This discovery provides physicians with a visual marker in identifying individuals that may carry germline BAP1 mutations. People having this syndrome should reduce their exposure to environmental risk factors such as UV radiation for melanoma and avoid erionite and asbestos exposure for mesothelioma. It will also help identify individuals who are at higher risk for melanomas which is usually cured with timely detection and to assist in the early detection of mesothelioma which typically leads to better prognosis.

"Identifying this gene as a cause of several cancers can tell us who is at risk in a family before the cancer develops," said Michele Carbone, MD, PhD, director of the UH Cancer Center and professor of pathology, John A. Burns School of Medicine. "We can advise patients to undergo routine exams and genetic testing for early diagnoses and treatment." Carbone is the leading author of the paper included in the August 30, 2012 issue of the Journal of Translational Medicine, published by BioMed Central.

This novel gene-testing has been patented by Carbone and colleagues and is performed exclusively at The Queen's Medical Center in Honolulu, Hawaii where they receive genetic samples from across the entire United States. Carbone previously discovered that individuals who carry BAP1 mutations are susceptible to developing mesothelioma and melanoma of the eye. This latest discovery builds on this and other research on the BAP1 mutation.


'/>"/>
Contact: Lori Strelow
lstrelow@cc.hawaii.edu
808-356-5753
University of Hawaii Cancer Center
Source:Eurekalert

Related medicine news :

1. Oxford University Press acquires American Journal of Hypertension
2. Queens University Belfast wins national environment award
3. Non-invasive treatment for children with obstructive sleep apnea suggested by Ben-Gurion University study
4. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
5. Hospital of the University of Pennsylvania selected to lead US nurse-training initiative
6. University of Pennsylvania and Novartis form alliance to expand use of personalized T cell cancer therapy
7. Boston University researchers expand synthetic biologys toolkit
8. Canadians super-sizing Canadas Food Guide servings: York University study
9. Tel Aviv University researcher says plants can see, smell, feel, and taste
10. Tel Aviv University research links childhood obesity to cancer risk
11. Marshall University scientist awarded NIH grant for lung cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Horizon Blue ... been honored as one of the nation’s most accomplished business technology innovators by ... received the recognition for technology achievements that have enabled the delivery of the ...
(Date:5/3/2016)... ... 03, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), one ... 2016 Asembia Specialty Pharmacy Summit held May 2-6, 2016 at the Wynn & ... conference for the specialty pharmacy industry, with thousands of pharmacy providers, pharma/biotech manufacturers, ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... announced that it is launching a new client service center in La Vergne, ... Texas, and will provide the full range of Empyrean client services. , “Our ...
(Date:5/3/2016)... ... May 03, 2016 , ... Park Cities Pet Sitter ... or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, 75229, 75230, 75231 ... Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park Cities areas of the ...
(Date:5/3/2016)... ... May 03, 2016 , ... For ... top Information and Communication Technology (ICT) companies in the annual Branham300 listing. For ... operating in Canada, as ranked by revenue. , “We are honored to ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... NEW YORK , May 2, 2016 ... the EMR (Electronic Medical Records) market in a recent ... International sales, vendor switches, Increased physician usage, a growing market ... trends were noted in Kalorama,s report EMR ... The report marks Kalorama,s seventh complete study of the ...
(Date:5/2/2016)... N.J. , May 2, 2016  Celsion ... development company, today announced data from the first ... escalating clinical trial (the OVATION Study) combining GEN-1, ... care for the treatment of newly-diagnosed patients with ... followed by interval debulking surgery.  In the first ...
(Date:4/29/2016)... , April 29, 2016 ... for Life Sciences, Product Development Capabilities in ... Science Customer Base . Indegene ... today announced the acquisition of Skura Corporation,s life ... leader in adaptive sales enablement technology for life ...
Breaking Medicine Technology: